Champions Oncology Inc

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Hackensack, New Jersey and currently employs 217 full-time employees. The firm is a technology-enabled research organization engaged in creating technology solutions to be utilized in drug discovery and development. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. Its pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development. The firm operates in one segment pertaining to oncology services. Its research platform is a proprietary bank of Patient Derived Xenograft (PDX) models. Its PDX models are deployed into advanced vivo and ex vivo pharmacology platforms, providing an insight into therapeutic programs. The PDX bank is characterized at the molecular, phenotypic and pharmacological levels, which provides a differentiated layer of data for its oncology dataset.